phosphorus has been researched along with bixalomer in 7 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (bixalomer) | Trials (bixalomer) | Recent Studies (post-2010) (bixalomer) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 17 | 4 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akizawa, T; Kameoka, C; Kaneko, Y; Kawasaki, S | 1 |
| Furukawa, K; Ikawa, T; Kato, K; Takahashi, J; Ueno, M; Yokoi, S; Yokouchi, S | 1 |
| Gen, S; Ikeda, N; Nobe, K; Nodaira, Y; Saito, K; Sasaki, T | 1 |
| Ban, A; Funao, K; Furumitsu, Y; Hata, K; Inoue, K; Makino, R; Okamura, M; Shima, H; Sugita, S; Yoshimoto, M | 1 |
| Ito, K; Kumata, C; Matsuzaka, K; Nakajima, Y; Ogata, H; Shishido, K; Takeshima, A; Wakasa, M | 1 |
| Akizawa, T; Kameoka, C; Kaneko, Y; Kanoh, H; Origasa, H | 1 |
| Kakuta, H; Taniguchi, K | 1 |
1 trial(s) available for phosphorus and bixalomer
| Article | Year |
|---|---|
Dose-finding study of bixalomer in patients with chronic kidney disease on hemodialysis with hyperphosphatemia: a double-blind, randomized, placebo-controlled and sevelamer hydrochloride-controlled open-label, parallel group study.
Topics: Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Hyperphosphatemia; Japan; Phosphorus; Polyamines; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Treatment Outcome | 2014 |
6 other study(ies) available for phosphorus and bixalomer
| Article | Year |
|---|---|
Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients.
Topics: Aged; Asian People; Female; Gastrointestinal Agents; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Treatment Outcome | 2013 |
Effects of switching from sevelamer hydrochloride to bixalomer on laboratory parameters in hemodialysis patients.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Calcium; Chelating Agents; Female; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lipid Metabolism; Lipids; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2014 |
Clinical effects of the new phosphorus binder, bixalomer in hemodialysis patients switched from sevelamer hydrochloride.
Topics: Abdominal Pain; Aged; Calcium; Chelating Agents; Constipation; Diarrhea; Dyspepsia; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Surveys and Questionnaires | 2014 |
Clinical experiences of bixalomer usage at our hospital.
Topics: Aged; Calcium; Chelating Agents; Female; Follow-Up Studies; Humans; Hydrogen-Ion Concentration; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer | 2014 |
Treatment of hyperphosphatemia with bixalomer in Japanese patients on long-term hemodialysis with gastrointestinal symptoms.
Topics: Abdominal Pain; Bicarbonates; Calcium; Chelating Agents; Cohort Studies; Constipation; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis | 2014 |
Bixalomer, a novel phosphate binder with a small swelling index, improves hyperphosphatemia in chronic kidney disease rat.
Topics: Adsorption; Animals; Hyperphosphatemia; Male; Phosphates; Phosphorus; Polyamines; Rats, Wistar; Renal Insufficiency, Chronic; Water | 2015 |